Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $69.37 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.60 | 1 | $0 (2021) |
| Lundbeck LLC | $14.52 | 1 | $0 (2022) |
| ITI, Inc. | $13.24 | 1 | $0 (2022) |
| Genentech USA, Inc. | $11.64 | 2 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $11.37 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $27.76 | 2 | Lundbeck LLC ($14.52) |
| 2021 | $41.61 | 4 | AstraZeneca Pharmaceuticals LP ($18.60) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/20/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: PRIMARY CARE | ||||||
| 10/29/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Virology & Specialty Care | ||||||
| 10/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Virology & Specialty Care | ||||||
| 04/21/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 28 | 28 | $4,273 | $1,679 |
| 2021 | 5 | 111 | 118 | $20,769 | $9,093 |
| 2020 | 9 | 257 | 600 | $31,610 | $9,732 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $3,503 | $1,102 | 31.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 14 | 14 | $770.00 | $577.50 | 75.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $7,950 | $2,736 | 34.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 27 | 27 | $5,697 | $2,308 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 22 | $3,982 | $1,882 | 47.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 27 | 29 | $2,315 | $1,488 | 64.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 15 | 15 | $825.00 | $678.45 | 82.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 74 | $14,030 | $4,180 | 29.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $6,000 | $1,871 | 31.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 36 | $4,068 | $1,459 | 35.9% |
| 87426 | Coronavirus ag ia | Office | 2020 | 23 | 23 | $2,460 | $995.06 | 40.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 47 | 66 | $2,640 | $515.38 | 19.5% |
| 87804 | Detection test for influenza virus | Office | 2020 | 14 | 28 | $980.00 | $425.02 | 43.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 15 | 15 | $900.00 | $241.07 | 26.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 28 | 288 | $432.00 | $23.08 | 5.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 12 | 50 | $100.00 | $21.58 | 21.6% |
About Crissy Sharpe, FNP
Crissy Sharpe, FNP is a Family healthcare provider based in Baker, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2018. The National Provider Identifier (NPI) number assigned to this provider is 1437659547.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Crissy Sharpe, FNP has received a total of $69.37 in payments from pharmaceutical and medical device companies, with $27.76 received in 2022. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($69.37).
As a Medicare-enrolled provider, Sharpe has provided services to 396 Medicare beneficiaries, totaling 746 services with total Medicare billing of $20,503. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Baker, LA
- Active Since 02/15/2018
- Last Updated 01/03/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1437659547
Products in Payments
- VYEPTI (Biological) $14.52
- CAPLYTA (Drug) $13.24
- Xofluza (Drug) $11.64
- NURTEC ODT (Drug) $11.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Baker
Mrs. Mallory Bankston, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $4,545
Dorothy Ewen, Np-C, NP-C
Family — Payments: $4,415
Elizabeth Mouton, Fnp, FNP
Family — Payments: $3,793
Hailey Murphy, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $3,665
Stephanie Nolan, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $3,085
Megan Dale
Family — Payments: $400.02